Behavior Genetics

, Volume 41, Issue 5, pp 691–699

Genetic Associations Between Fibrinogen and Cognitive Performance in Three Scottish Cohorts

  • Riccardo E. Marioni
  • Ian J. Deary
  • Gordon D. Murray
  • Gordon D. O. Lowe
  • Mark W. J. Strachan
  • Michelle Luciano
  • Lorna M. Houlihan
  • Alan J. Gow
  • Sarah E. Harris
  • Ann Rumley
  • Marlene C. Stewart
  • F. Gerry R. Fowkes
  • Jackie F. Price
Original Research

DOI: 10.1007/s10519-011-9449-2

Cite this article as:
Marioni, R.E., Deary, I.J., Murray, G.D. et al. Behav Genet (2011) 41: 691. doi:10.1007/s10519-011-9449-2

Abstract

There is increasing evidence to suggest that elevated plasma levels of fibrinogen are associated with late-life cognitive performance. This study tested the association of single nucleotide polymorphisms in the fibrinogen α (FGA) and β (FGB) genes with cognitive performance. Data were analysed from three community-dwelling populations of older persons (>50 years) in central Scotland: the Aspirin for Asymptomatic Atherosclerosis (AAA) Trial (n = 2,091), the Edinburgh Type 2 Diabetes Study (ET2DS, n = 1,066), and the Lothian Birth Cohort 1936 (LBC1936, n = 1,091). Cognition was assessed using a battery of five, seven, and four psychometric tests, respectively. This information was used to derive a general cognitive factor. Weakly significant associations were found between the rs4220 (FGB), and rs2227412 (FGB) SNPs and a single test of cognitive performance in the AAA Trial (p < 0.05). These findings did not replicate in the LBC1936 or ET2DS cohorts, except for the rs2227412 SNP, which was significantly associated with the general cognitive factor in the ET2DS (p = 3.3 × 10−4). A summary term that combined results from all three studies suggested that the rs2227412 genotype associated with reduced cognitive ability also associated with higher plasma fibrinogen levels. These findings suggest a tentative role for fibrinogen as a determinant of late-life cognitive performance and justify further attempts at replication in older persons.

Keywords

AgeingFibrinogenCognitionSingle nucleotide polymorphismDiabetes

Supplementary material

10519_2011_9449_MOESM1_ESM.doc (86 kb)
Supplementary material 1 (DOC 86 kb)

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  • Riccardo E. Marioni
    • 1
  • Ian J. Deary
    • 2
  • Gordon D. Murray
    • 1
  • Gordon D. O. Lowe
    • 3
  • Mark W. J. Strachan
    • 4
  • Michelle Luciano
    • 2
  • Lorna M. Houlihan
    • 2
  • Alan J. Gow
    • 2
  • Sarah E. Harris
    • 2
    • 5
  • Ann Rumley
    • 3
  • Marlene C. Stewart
    • 1
  • F. Gerry R. Fowkes
    • 1
  • Jackie F. Price
    • 1
    • 6
  1. 1.Centre for Population Health SciencesThe University of Edinburgh, Medical SchoolEdinburghScotland, UK
  2. 2.Department of PsychologyCentre for Cognitive Ageing and Cognitive Epidemiology, University of EdinburghEdinburghScotland, UK
  3. 3.Division of Cardiovascular and Medical SciencesUniversity of GlasgowGlasgowScotland, UK
  4. 4.Metabolic UnitWestern General HospitalEdinburghUK
  5. 5.Medical Genetics SectionCentre for Cognitive Ageing and Cognitive Epidemiology, University of EdinburghEdinburghScotland, UK
  6. 6.Centre for Cognitive Ageing and Cognitive Epidemiology, University of EdinburghEdinburghScotland, UK